Back to dashboard
All PlansCoverageMedium impact

Cochlear Implants

Regence BlueShield·ENT (Ear, Nose & Throat), Audiology, General Surgery·Medical Policy
Effective date
Oct 1, 2026
We identified it
Jul 7, 2026
Days to comply
86 days

Summary

This is a NEW cochlear implant coverage policy effective October 1, 2026, establishing medical necessity criteria for cochlear implant implantation and replacement across four scenarios: bilateral hearing loss (standard implants or hybrid systems), and single-sided deafness. The policy defines specific audiometric thresholds, hearing aid trial requirements, contraindications, and documentation requirements that billing and clinical teams must use to determine coverage eligibility.

Action Required

Before Oct 1, 2026
REQUIREMENTS: Before October 1, 2026: Providers and billing team must review and implement this new policy: 1. Clinical Documentation Team: Update patient intake forms and pre-operative checklists to capture all required documentation per Criteria I-IV, including: (a) Audiometric thresholds (pure-tone averages at 500Hz, 1000Hz, 2000Hz, 4000Hz as applicable); (b) Hearing aid trial results with specific sentence recognition scores (≤50% for adults, ≤30% for children on open-set tests); (c) Contraindication screening (acoustic nerve lesions, middle ear infections, tympanic perforation, cochlear development absence, willingness for rehabilitation); (d) FDA approval verification of device; (e) Progressive hearing loss documentation if applicable (for Criterion I.A.1.b); (f) Hybrid system specific thresholds if applicable (Criterion II.D detailed frequency-specific requirements). 2. Billing Team: Create internal policy reference guide distinguishing four coverage pathways: Pathway 1 (Criterion I - bilateral standard implants, any age), Pathway 2 (Criterion II - bilateral hybrid systems, age 18+ only), Pathway 3 (Criterion III - single-sided deafness, age 5+ only), Pathway IV (implant replacement for non-functional or inadequately responsive devices). Train team on specific exclusions (non-medically necessary per Criterion V if any Criterion I-III requirement unmet; Criterion VI for replacements that don't meet functional criteria). 3. Prior Authorization Process: Implement pre-authorization requirement for all cochlear implant cases to verify the applicable criterion pathway is met before surgery authorization. Ensure documentation package includes audiograms, hearing aid trial reports, contraindication screening, and device FDA approval status. 4. Providers: Ensure informed consent discussions document patient understanding that repeat hearing tests/hearing aid trials are not required if patient previously met Criteria I.A and II.A (per policy note: unlikely natural hearing will improve). FAILURE TO IMPLEMENT: Claims submitted without appropriate medical necessity documentation per the applicable criterion (I, II, III, or IV) will be denied as not meeting policy requirements. Hybrid system implants billed to members without age ≥18 verification will be denied. Single-sided deafness implants for patients under age 5 will be denied.